Venlafaxine: Discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites
- 29 April 1999
- Vol. 32 (3) , 198-211
- https://doi.org/10.1002/(sici)1098-2396(19990601)32:3<198::aid-syn6>3.0.co;2-2
Abstract
Using an in vivo electrophysiological paradigm, venlafaxine and paroxetine displayed similar potency for suppressing the firing activity of dorsal raphe 5‐HT neurons (ED50: 233 and 211 μg/kg i.v., respectively), while venlafaxine was three times less potent than desipramine (ED50: 727 and 241 μg/kg i.v., respectively) to suppress the firing activity of locus coeruleus NE neurons. The selective 5‐HT1A receptor antagonist WAY 100635 (100 μg/kg, i.v.) reversed the suppressant effect of venlafaxine and paroxetine on the firing activity of 5‐HT neurons and the α2‐adrenoceptor antagonist piperoxane (1 mg/kg, i.v.) reversed those of venlafaxine and desipramine on the firing activity of NE neurons. The ED50 of venlafaxine on the firing activity of 5‐HT neurons was not altered (ED50: 264 μg/kg) in noradrenergic‐lesioned rats, while the suppressant effect of venlafaxine on the firing activity of NE neurons was greater in serotonergic‐lesioned rats (ED50: 285 μg/kg). Taken together, these results suggest that, in vivo, venlafaxine blocks both reuptake processes, its potency to block the 5‐HT reuptake process being greater than that for NE. Since the affinities of venlafaxine for the 5‐HT and NE reuptake carriers are not in keeping with its potencies for suppressing the firing activity of 5‐HT and NE neurons, the suppressant effect of venlafaxine on the firing activity of 5‐HT and NE neurons observed in vivo may not be mediated solely by its action on the [3H]cyanoimipramine and [3H]nisoxetine binding sites. In an attempt to unravel the mechanism responsible for this peculiarity, in vitro superfusion experiments were carried out in rat brain slices to assess a putative monoamine releasing property for venlafaxine. (±)Fenfluramine and tyramine substantially increased the spontaneous outflow of [3H]5‐HT and [3H]NE, respectively, while venlafaxine was devoid of such releasing properties. Synapse 32:198–211, 1999.Keywords
This publication has 56 references indexed in Scilit:
- Blockade of 5‐Hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramineBritish Journal of Pharmacology, 1998
- Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5‐hydroxtryptamine systemBritish Journal of Pharmacology, 1997
- A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholiaJournal of Psychiatric Research, 1996
- Effect of Pindolol on the Function of Pre- and Postsynaptic 5-HT1A Receptors: In Vivo Microdialysis and Electrophysiological Studies in the Rat BrainNeuropsychopharmacology, 1996
- [3H]Nisoxetine—A radioligand for noradrenaline reuptake sites: Correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatmentsNeuropharmacology, 1996
- Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomesLife Sciences, 1993
- Metabolic disposition of14C-venlafaxine in mouse, rat, dog, rhesus monkey and manXenobiotica, 1993
- Denervation supersensitivity to serotonin in rat forebrain: Single cell studiesBrain Research, 1979
- Afferent projections to the rat locus coeruleus as determined by a retrograde tracing techniqueJournal of Comparative Neurology, 1978
- The effects of certain drugs on the uptake and release of [3H]noradrenaline in rat whole brain homogenatesCanadian Journal of Physiology and Pharmacology, 1976